Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of STIP1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of STIP1 mRNA | affects expression | 21346803
|
C024709 |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to STIP1 protein | affects binding | 16533022
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of STIP1 mRNA | increases expression | 18648102
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of STIP1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of STIP1 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of STIP1 mRNA | increases expression | 12205029
|
D003913 |
Dextroamphetamine |
SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of STIP1 mRNA] | decreases reaction|increases expression | 12205029
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of STIP1 mRNA | decreases expression | 20018196
|
C110172 |
BHTOH-QM |
BHTOH-QM binds to STIP1 protein | affects binding | 16533022
|
C053541 |
bicalutamide |
bicalutamide results in decreased expression of STIP1 mRNA | decreases expression | 15638997
|
C110904 |
capecitabine |
STIP1 protein results in decreased susceptibility to capecitabine | decreases response to substance | 16734730
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of STIP1 mRNA | decreases expression | 15331540
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of STIP1 mRNA | decreases expression | 11906922
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of STIP1 mRNA | increases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of STIP1 mRNA | decreases expression | 18042831
|
C025034 |
doxifluridine |
STIP1 protein results in decreased susceptibility to doxifluridine | decreases response to substance | 16734730
|
D004642 |
Emodin |
Emodin results in decreased expression of STIP1 mRNA | decreases expression | 16045814
|
D004958 |
Estradiol |
Estradiol results in increased expression of STIP1 mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of STIP1 mRNA | increases expression | 14664709
|
C106014 |
gedunin |
gedunin results in increased expression of STIP1 mRNA | increases expression | 17010675
|
D008694 |
Methamphetamine |
Methamphetamine results in increased expression of STIP1 mRNA | increases expression | 19149911
|
D015741 |
Metribolone |
Metribolone affects the localization of STIP1 protein | affects localization | 17440980
|
D015741 |
Metribolone |
Metribolone results in increased expression of STIP1 protein | increases expression | 17152098
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of STIP1 mRNA | increases expression | 17616710
|
C041786 |
palm oil |
palm oil results in decreased expression of STIP1 mRNA | decreases expression | 18042831
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STIP1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of STIP1 mRNA | increases expression | 18301758
|
D011374 |
Progesterone |
Progesterone affects the expression of STIP1 mRNA | affects expression | 17251523
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of STIP1 protein | decreases expression | 16548065
|
C050414 |
tripterine |
tripterine results in increased expression of STIP1 mRNA | increases expression | 17010675
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
7.78 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.78 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.92 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.05 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.63 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.20 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.20 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.76 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
9.64 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.64 | 15238619 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.81 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.13 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.05 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
2.87 | 12972520 18473752 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.87 | 17388661 15136595 11325840 15093573 18234424 18323546 17020986 16978400 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.87 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.87 | 16675129 12948864 17261762 19861407 17289903 14630087 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.87 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.87 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.25 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.50 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.50 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.50 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
8.50 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.50 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.68 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.36 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.36 | 16201981 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 16120746 18850075 18670907 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.51 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
19.56 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
19.56 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
19.56 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.56 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
19.56 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.49 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.49 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.49 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.02 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
3.31 | 18448328 18473752 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.60 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.60 | 17141729 14669216 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.61 | 17465463 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.20 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.20 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.77 | 15276878 18295254 18093676 15643279 17010015 18372110 16651033 18483878 17979934 12913760 16413132 18433785 16989017 12161096 18710439 11948286 12388444 16614059 10498854 10700343 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.61 | 8156756 11298694 12868966 8970840 11906362 2524372 14531868 18759878 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.33 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.30 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.90 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.16 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.24 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.28 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.33 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.33 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.33 | 9653073 6679447 1440618 18692083 6482804 7440962 11289319 16192314 8291058 9328219 18289764 9022650 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
11.33 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.33 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.61 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.30 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.92 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.92 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.69 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.58 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.85 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.32 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.32 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.01 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.96 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.96 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
6.96 | 16510608 15150132 15623463 15547721 15264214 16805852 16704527 15547733 15878914 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.86 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.96 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
11.96 | 17967931 19551842 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.96 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.81 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.49 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
19.49 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Emodin |
19.49 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.49 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.01 | 8708960 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.30 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.84 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.83 | 15172196 16376943 11014644 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.22 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.41 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.21 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.08 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.32 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.31 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.57 | 19176532 19772884 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.57 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.82 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.61 | 17606976 16135485 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.54 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 16959395 16354765 8697196 18606429 15340226 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.40 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.00 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
5.30 | 17658665 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.42 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.73 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.68 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.68 | 18850075 18670907 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.12 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.19 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.48 | 16517039 7193160 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.68 | 20412841 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.68 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.68 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
11.51 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.51 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.51 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.81 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.15 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.23 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.54 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.54 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
21.51 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
21.51 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
21.51 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
21.51 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
21.51 | 15610895 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.39 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.41 | 17658394 18587576 17008537 18172266 17296974 17802794 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
4.83 | 17077332 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.93 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.75 | 11830472 10052129 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.76 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.07 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
4.77 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.77 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.77 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.77 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
6.86 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
6.86 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.86 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.02 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.02 | 598648 1399818 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.02 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.23 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.69 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.40 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.00 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.62 | 11408345 17203775 11807958 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.62 | 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.27 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.59 | 16388313 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.58 | 16801185 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.31 | 1613127 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.30 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.06 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.85 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.72 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.72 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.64 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.64 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
6.00 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
6.00 | 12972520 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
7.92 | 16374040 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
7.92 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.92 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.52 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.23 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.11 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.79 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.79 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.78 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.53 | 8761367 16115947 15176712 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.68 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.13 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.25 | 18674790 20132043 19632207 18457598 16723640 20518802 11836018 21332399 17217161 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.25 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
20.08 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
20.08 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
20.08 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
20.08 | 14694615 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.50 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.81 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.65 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.65 | 16525653 17393432 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.46 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.11 | 11332152 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.28 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.26 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.05 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.69 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.98 | 11222880 11896295 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.85 | 18487222 19011039 17914592 15638997 19240160 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.85 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.85 | 16740699 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.20 | 16636934 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.22 | 3692021 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.63 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.40 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.40 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 16192470 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.30 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.07 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.32 | 17575124 12958204 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.85 | 12837982 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.73 | 6582329 7505956 1399818 6587162 3712494 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.47 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.27 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
11.27 | 14692829 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.28 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.28 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.77 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.56 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.23 | 17120751 |